Walleye Capital LLC Repligen Corp Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

A detailed history of Walleye Capital LLC transactions in Repligen Corp stock. As of the latest transaction made, Walleye Capital LLC holds 2,800 shares of RGEN stock, worth $349,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,800
Previous 35,600 92.13%
Holding current value
$349,244
Previous $4.49 Million 90.73%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $6.18 Million - $8.63 Million
51,597 Added 119.69%
94,707 $14.1 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $5.15 Million - $7.86 Million
42,957 Added 28076.47%
43,110 $5.43 Million
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $26,129 - $31,888
153 New
153 $28,000
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $426,610 - $555,715
3,082 New
3,082 $435,000
Q2 2022

Aug 08, 2022
SELL
$140.68 - $188.02 $324,267 - $433,386
-2,305 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $371,542 - $594,597
2,305 New
2,305 $434,000
Q4 2021

Mar 03, 2022
SELL
$247.59 - $304.47 $350,092 - $430,520
-1,414 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $68,948 - $114,770
354 Added 33.4%
1,414 $409,000
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $175,822 - $234,207
1,060 New
1,060 $212,000
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $236,465 - $296,626
-1,311 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $229,968 - $320,803
-1,553 Reduced 54.22%
1,311 $251,000
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $207,261 - $258,259
2,704 Added 1690.0%
2,864 $220,000
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $8,672 - $13,752
160 New
160 $14,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email